Innovation Pharmaceuticals Inc (IPIX)

[Ernesto]

Only Kevetrin will take more than three years to approval. Assuming good Prurisol/B-OM phase 2 results we will likely have B ABSSI, B-OM and Prurisol approved within three years.

Prurisol will have 505, high efficacy, low side effects and oral delivery.
The B's will have fast track and a novel MoA.

I think we ultimately sell Prurisol and the Brilacidin platform and then get acquired for Kevetrin within three years.